Kinvard Bio
PrivateLast Round
Grant
Jul 29, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kinvard Bio operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. Its latest recorded funding round was a Seed round in February 2025.
Kinvard Bio is a drug discovery company developing antibiotics intended to combat multidrug-resistant bacterial infections. The company offers rational drug design and a proprietary synthetic chemistry platform to create a differentiated class of ribosome-targeting antibacterials, including oxepanoprolinamides, enabling clients to address the critical global health threat of antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kinvard Bio Comparables
Compare Kinvard Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| APY Therapeutics | 86% | |
| Cūrza | 81% | |
| Macrolide Pharmaceuticals | 79% |
For institutional investors. Book with your work email.
Kinvard Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 29, 2025 | ||||
| Seed | Feb 24, 2025 |
For institutional investors. Book with your work email.
Kinvard Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Kineticos Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 42% MoM.
- May 16, 2026
Monthly visitors grew 196% MoM.
For institutional investors. Book with your work email.
Kinvard Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kinvard Bio's valuation, stock price, and market status.
Is Kinvard Bio a public or private company?
Kinvard Bio is a private company.
What is the current stock price of Kinvard Bio?
Kinvard Bio is a private company, so its shares have no public market price. Caplight tracks Kinvard Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kinvard Bio worth (valuation)?
Valuation information for Kinvard Bio is not publicly available.
Can I buy Kinvard Bio stock?
Kinvard Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kinvard Bio's last funding round?
Kinvard Bio's most recent funding round was Grant on July 29, 2025.
Who are the main investors in Kinvard Bio?
Key investors in Kinvard Bio include Kineticos Ventures.
Will Kinvard Bio IPO soon?
No public IPO plans have been announced for Kinvard Bio.
How can I track Kinvard Bio secondary market activity?
Caplight tracks bids, offers, and trades in Kinvard Bio's shares on secondary markets.